Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
News and Views
Nature Medicine  5, 15 - 17 (1999)
doi:10.1038/4691

Tobacco—the growing epidemic

Richard Peto, Zheng−Ming Chen & Jillian Boreham

ICRF/MRC Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) University of Oxford Radcliffe Infirmary Oxford OX2 6HE, U.K. zhengming.chen@ctsu.ox.ac.uk

The largest study ever undertaken to examine the health effects of tobacco finds that there are already a million deaths a year from smoking in China, and it predicts large increases in mortality over the next few decades. This pattern is likely to be repeated in other developing countries.
China, with 20 percent of the world's population, produces and consumes about 30 percent of the world's cigarettes. The first nationwide study of the effects of smoking in any developing country now shows that China already suffers almost a million deaths a year from tobacco1, 2 (the full reports are freely available at http://www.bmj.com). This is more than in any other country, and the hazards are expected to increase substantially over the next few decades as a delayed effect of the recent rise in cigarette use. To monitor the current and future hazards of tobacco use, the Chinese study consisted of two parts: one retrospective1 and one prospective2. The retrospective study, which assessed current mortality from tobacco use in China, was of a new design (see legend to Fig. 1) and involved analysis of one million deaths. The prospective study (the early results from which confirm the retrospective results) began by interviewing a quarter of a million adults and will continue for decades, monitoring the long−term growth of the epidemic.

Figure 1. For the one million people who died between 1986 and 1988 in 24 cities (filled circles on map) and in various rural areas of China (open circles), the disease that caused death was determined and the family was interviewed to discover what the deceased person had smoked.
Figure 1 thumbnail

The smoking habits of 0.7 million Chinese adults who had died of neoplastic, respiratory or vascular causes were compared with the habits of the 'reference group' of 0.2 million adults who had died of other causes. The threefold excess of lung cancer deaths among smokers could then be inferred from the excess, in comparison with the reference group, of smokers in the lung cancer death category. (Similarly, the excesses of various other diseases among smokers could be calculated.) In each city the local relative risk, the local prevalence of smoking and the local lung cancer rate (standardized for age by averaging the seven death rates at ages 35−9, 40−4...65−9) could then be combined to calculate the absolute lung cancer rates among smokers and non−smokers separately (see Fig. 2). [This figure was reproduced from 1 with permission from the Br. Med. J.]



Full FigureFull Figure and legend (19K)
Apart from HIV/AIDS, tobacco is the only major cause of death that is increasing rapidly3. Worldwide, smoking caused about 3 million deaths in 1990, out of a total of 30 million adult deaths from all causes, and it will cause about 10 million in 2030, out of a total of about 60 million4, 5. Most of this projected increase in tobacco deaths will take place in Asia, Africa and South America. Until recently, such projections had to be based chiefly on extrapolation from studies in developed countries such as Britain or the United States6, 7. But, most of the world's one billion smokers live in developing countries, where the effects of smoking could well be different, so local studies are urgently needed.

This new Chinese evidence needs to be seen in the context of Western epidemiological evidence, which demonstrates the peculiarly long delay between cause and full effect. In countries such as Britain and the United States, most of those who now smoke cigarettes began to do so in early adult life, and recent UK/US prospective studies show that about half of all persistent smokers are eventually killed by their habit6, 7. Fifty percent of these tobacco deaths occur in middle age (here defined as 35−69 years), and half in old age4. But only those who have smoked cigarettes since early adulthood are at particularly high risk in middle and old age, so earlier UK/US prospective studies—conducted after the rise in cigarette use but only halfway through the increase in mortality—misleadingly suggested that the risks of tobacco use were lower8. The need for prolonged smoking before the full risks become evident means that if a country experiences a nationwide surge in cigarette use by young adults then this will cause a large increase in tobacco deaths about a half−century later. Until then, however, there may be several decades during which cigarette consumption is high but mortality from tobacco is still relatively low.

In developed countries, cigarette smoking became popular during the first half of the twentieth century, so the main increase in tobacco deaths has been seen during the second half of this century. For example, mean US cigarette consumption per adult in 1910, 1930 and 1950 was 1, 4 and 10 a day, respectively, after which it remained fairly constant for a few decades. Therefore, the proportion of all US deaths at ages 35−69 attributed to tobacco rose from 12 percent in 1950 to 33 percent in 1990 (4).

In many developing countries, cigarette smoking became widespread only during the last 30 years, so the main consequences of this will emerge next century. For example, the US pattern of an increase in cigarette smoking between 1910 and 1950 has been repeated 40 years later in China. Mean cigarette consumption per Chinese man in 1952, 1972 and 1992 was 1, 4 and 10 per day, respectively, after which it seems to have leveled off1. Both the retrospective study and the early results from the prospective study in China indicate that in 1990 tobacco caused about 12 percent of adult male deaths, and by 2030 it will probably be a cause of about one third of them. About two thirds of young Chinese men become cigarette smokers in early adult life, and in China, as in America, about half of those who do so will eventually be killed by their habit. Thus, about one third of all young Chinese men will eventually, in middle or old age, be killed by tobacco. As about 10 million a year reach manhood in China, the annual number of tobacco deaths will rise from almost 1 million now to about 3 million in the middle of the next century. Hence, there will be a total of about 100 million deaths caused by tobacco in China during the first half of the next century.

But even if the overall 50 percent hazard is about the same in China as elsewhere, these new studies show that the chief diseases by which tobacco causes death are very different in China (and, within China, between one city and another). In the United States, for example, tobacco causes far more deaths from heart attacks than from emphysema, whereas in China the opposite is true. Of Chinese tobacco deaths, almost half involve emphysema, and the proportions involving tuberculosis, esophageal cancer, stomach cancer and liver cancer are each about as large (5−8 percent) as the proportions involving heart disease or stroke.

Lung cancer, which was the first major disease to be reliably linked to smoking in Western studies, is also an important hazard for Chinese smokers, but, unexpectedly, there is a tenfold variation from one Chinese city to another in the magnitude of this hazard (see Fig. 2). In each city, the lung cancer rate is about three times as great among smokers as among non−smokers, but there is a tenfold variation in the non−smoker lung cancer rates, which in some cities, perhaps chiefly because of domestic heating and cooking fumes, are ten times greater than the rates among US non−smokers. There was even wider variation between one city and another in the non−smoker emphysema death rates, which in some cities were almost 100 times greater than those in U.S. non−smokers.

Figure 2. Death rates at ages 35−69 from lung cancer in various parts of China: smokers versus non−smokers (1986−1988).
Figure 2 thumbnail

The lung cancer rates show wide variation, with extremely high rates in some cities among non−smokers and, particularly, among smokers. In comparison, the nationwide US lung cancer death rates in 1990, similarly standardized for age, were 1.4 per 1,000 men and 0.6 per 1,000 women, and were 0.1 per 1,000 male or female US non−smokers3. [This figure was reproduced from 1 with permission from the Br. Med. J.]



Full FigureFull Figure and legend (17K)
From a public health perspective, the main finding of the Chinese study is the alarming overall risk of death, which can be stated in various ways: tobacco will eventually kill one third of all young men in China; it will kill half of all persistent cigarette smokers; there will be one million tobacco deaths a year in China during the first decade of the next century, 2 million a year by 2025, 3 million a year by mid−century, and a total of 100 million during the first 50 years of the next century. In comparison, most of the intriguing little details of how tobacco kills are of less immediate importance.

The chief exception, however, concerns women. The bad news is that if women smoke like men they die like men; their overall risks are about the same. But the good news is that on the whole Chinese women don't smoke like men; unexpectedly (and unexplainedly), the proportion of women who became smokers before the age of 25 has decreased enormously over the past few decades. If this low uptake rate of smoking by young women continues then, although the proportion of deaths attributed to smoking in 1990 and in 2030 will increase from 12 percent to about 33 percent for Chinese men, it will decrease from 3 percent to 1 percent for Chinese women. Tobacco would then be responsible for most of the difference in life expectancy between men and women in China.

The only hope of substantially limiting worldwide tobacco deaths in the first half of the next century is for many of the adults who now smoke to stop doing so, because discouraging young people from starting will take half a century to produce its main health benefits. Western studies show that, even in middle age, cessation of smoking is remarkably effective, removing most of the 50 percent risk of death from tobacco if smoking persists. Stopping at earlier ages is even more effective6. Britain, which is now experiencing the most rapid decrease in the world in premature deaths from tobacco, shows that large improvements are possible: over the past 30 years, UK cigarette sales have halved, as have UK tobacco deaths in middle age3. At present, however, such changes are chiefly limited to educated Western smokers; Chinese smokers, for example, rarely stop until they are too ill to continue. So, the worldwide network of epidemiological studies of tobacco deaths in developing countries—such as India, Mexico, Cuba, Egypt and South Africa—that are being modeled on these Chinese studies, is likely to document a growing epidemic in these nations over the next few decades.

 Top
REFERENCES
  1. Liu, B.Q. et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. Br.Med. J. 317, 1411-1422 (1998). | ISI |
  2. Niu, S.R. et al. Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. Br.Med. J. 317, 1423-1424 (1998). | ISI |
  3. Ad Hoc Committee on Health Research. Investing in health research and development. The World Health Organization, Geneva, Switzerland (1996).
  4. Peto, R., Lopez, A.D., Boreham, J., Thun, M. & Heath, C. Jr. Mortality from smoking in developed countries 1950-2000: Indirect estimates from national vital statistics. Oxford University Press (1994).
  5. Murray, C.J.L. & Lopez, A.D. (eds). In The global burden of disease. (Harvard School of Public Health, Boston, Massachusetts, 1996).
  6. Doll, R., Peto, R., Wheatley, K., Gray, R. & Sutherland, I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br.Med. J. 309, 901-911 (1994). | ISI |
  7. Thun, M.J. et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N. Engl. J. Med. 337, 1705-1714 (1997). | PubMed | ISI |
  8. U.S. Department of Health & Human Services. Reducing the health consequences of smoking: 25 years of progress. A Report of the Surgeon General. U.S. Department of Health & Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411 (1989).
 Top
Acknowledgments
We thank the Chinese principal investigators1, 2 and our funding organizations.

FULL TEXT
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Abstract
Figures & Tables
Acknowledgments
References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1999 Nature Publishing Group | Privacy policy